$PLx Pharma (PLXP.US)$PLx Pharma Says As Result Of Receiving...
$PLx Pharma (PLXP.US)$ PLx Pharma Says As Result Of Receiving Written Notice From Nasdaq Listing Qualifications Department; Says Unless Co. Requests Appeal Of Nasdaq Determination, Co.'s Common Stock Will Be Suspended From Nasdaq Capital Market On Apr. 13, 2023
免责声明：社区由Moomoo Technologies Inc.提供，仅用于教育目的。
更多信息
评论
登录发表评论
